Literature DB >> 3973259

Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction.

D M Mirvis.   

Abstract

The QT interval is a clinically important electrocardiographic measurement. This study attempted to determine 1) whether this interval was spatially distributed in a physiologically meaningful way on the torso of normal subjects, and 2) if these spatial patterns were altered in patients with acute myocardial infarction. To do so, 30 patients were studied within 72 hours of the onset of acute myocardial infarction (15 with an anterior and 15 with a posterior lesion) along with 50 normal control subjects. Electrocardiographic signals were registered from 150 torso electrodes; the QT interval in each lead was determined by a combined automated-manual method, and the durations displayed as "isointerval maps." In the normal subjects, the difference between the longest and shortest interval in each case was 59.4 +/- 12.9 ms. Long QT intervals were spatially located over the left lateral torso and short QT intervals were found over the right inferior chest. Acute infarction modified this distribution in relation to lesion location; the longest QT intervals were centrally positioned in anterior infarction and caudally located in inferior infarction. Thus, QT intervals in normal and abnormal states have distinctive spatial distributions that are consistent with known regional myocardial electrophysiology.

Entities:  

Mesh:

Year:  1985        PMID: 3973259     DOI: 10.1016/s0735-1097(85)80387-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

1.  Measuring QT dispersion: man versus machine.

Authors:  A Murray; N B McLaughlin; R W Campbell
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Magnetocardiography in coronary artery disease with a new system in an unshielded setting.

Authors:  Birgit Hailer; Illja Chaikovsky; Sabine Auth-Eisernitz; Harald Schäfer; Fritz Steinberg; Dietrich H W Grönemeyer
Journal:  Clin Cardiol       Date:  2003-10       Impact factor: 2.882

3.  Clinical Utility of Electrocardiographic ST-Segment Area for Predicting Unsatisfactory Outcomes Following Thrombolytic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  [Pathophysiologic relevance and prognostic value of QT dispersion].

Authors:  M Zabel; S H Hohnloser
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-12

5.  [Not Available].

Authors:  P Gödde; H P Müller; K Czerski; B Kessler; R Agrawal; M Oeff; H P Schultheiss
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1998-02

6.  Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects.

Authors:  N B McLaughlin; R W Campbell; A Murray
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

7.  Computerised measurements of QT dispersion in healthy subjects.

Authors:  Y Gang; X H Guo; R Crook; K Hnatkova; A J Camm; M Malik
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

8.  The relation of QT dispersion and localized QT difference to coronary pathology in a population with unstable coronary artery disease.

Authors:  Milos Kesek; Anders Englund; Tomas Jernberg; Bo Lagerqvist; Bertil Lindahl
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

9.  Effects of slow coronary artery flow on QT interval duration and dispersion.

Authors:  Ramazan Atak; Hasan Turhan; Alpay T Sezgin; Ozkan Yetkin; Kubilay Senen; Mehmet Ileri; Onur Sahin; Orhan Karabal; Ertan Yetkin; Emine Kutuk; Deniz Demirkan
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

10.  Differential effects of propofol and sevoflurane on QT interval during anesthetic induction.

Authors:  Makito Oji; Yoshiaki Terao; Tomomi Toyoda; Tomoyuki Kuriyama; Kosuke Miura; Makoto Fukusaki; Koji Sumikawa
Journal:  J Clin Monit Comput       Date:  2012-12-15       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.